Defunct Company
Total Trials
19
As Lead Sponsor
18
As Collaborator
1
Total Enrollment
2,467
NCT00355745
Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2006
Completion: Jul 31, 2009
NCT00781118
AngelMed for Early Recognition and Treatment of STEMI
Phase: Phase 3
Start: Dec 31, 2008
Completion: May 17, 2017
NCT00985361
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
Start: Oct 31, 2009
Completion: Mar 31, 2010
NCT01485718
Effect of Daily Glucomannan in Overweight Patients
Phase: Phase 4
Start: Oct 31, 2011
Completion: Mar 31, 2012
NCT01755299
Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
Start: Dec 31, 2012
Completion: Apr 30, 2013
NCT02048280
Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support
Completion: Apr 30, 2015
NCT01854138
Evaluating Advantages of Prevena After Hip and Knee Arthroplasty
Start: Jan 31, 2014
NCT02040675
Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias
Start: Feb 28, 2014
Completion: Mar 31, 2016
NCT03026205
ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2017
Completion: Jan 31, 2017
NCT03355248
Satisfaction Following Cesarean Section
Start: Aug 18, 2017
Completion: Aug 14, 2020
NCT04635696
Ethyl Chloride for NPWT
Start: Jan 7, 2019
Completion: Dec 10, 2020
NCT04440475
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
Start: Jun 28, 2020
Completion: Jan 30, 2022
NCT04316481
IDE-ALERTS Continued Access Study
Start: Sep 22, 2020
Completion: Jan 20, 2022
NCT05633277
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Start: Sep 30, 2020
Completion: Mar 31, 2024
NCT05175547
Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke
Start: Oct 30, 2021
Completion: Feb 28, 2024
NCT05172934
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
Start: Mar 15, 2022
Completion: Nov 1, 2023
NCT05412927
AngelMed Guardian® System PMA Post Approval Study
Start: Sep 7, 2022
Completion: Dec 31, 2026
NCT06949228
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
Phase: Phase 2/3
Start: Jul 30, 2025
Completion: May 30, 2028
NCT06927245
Use of the PTEye Device to Reduce Inadvertent Parathyroidectomy During Thyroid Surgery
Start: Sep 1, 2025
Completion: Dec 31, 2025